{"success":true,"data":{"pressRelease":{"id":"140990","rtpr_id":"nBw4dPMpPa-20260910","ticker":"SMTI","exchange":"NASDAQ","all_tickers":["SMTI"],"title":"Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI","author":"Business Wire","published_at":"2026-09-10T20:10:00.216Z","article_body":"Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates\nAdequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI\n\nFormer Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law\nfirm of Kahn Swick & Foti\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ksfcounsel.com%2F&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=Kahn+Swick+%26amp%3B+Foti&index=1&md5=fd7f7d19ac27ca4fedc258b1cbe11aab)\n, LLC (“KSF”) are investigating the proposed sale of Sanara MedTech\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqcm-smti%2F&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=Sanara+MedTech&index=2&md5=e4a914385aace2d10264fe7e56cdc911)\nInc. (NasdaqCM: SMTI) to MiMedx Group, Inc. (NasdaqCM: MDXG). Under the terms\nof the proposed transaction, shareholders of Sanara will receive $33.00 in\ncash and 0.4735 shares of MiMedx common stock for each share of Sanara that\nthey own. KSF is seeking to determine whether this consideration and the\nprocess that led to it are adequate, or whether the consideration undervalues\nthe Company.\n\nIf you believe that this transaction undervalues the Company and/or if you\nwould like to discuss your legal rights regarding the proposed sale, you may,\nwithout obligation or cost to you, e-mail or call KSF Managing Partner Lewis\nS. Kahn (lewis.kahn@ksfcounsel.com (mailto:lewis.kahn@ksfcounsel.com) ) toll\nfree at any time at (833) 538-3612, or visit\nhttps://www.ksfcounsel.com/cases/nasdaqcm-smti/\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqcm-smti%2F&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqcm-smti%2F&index=3&md5=40e0900b5fa6c593f239ab7b03742f17)\nto learn more.\n\nTo learn more about KSF, whose partners include the Former Louisiana Attorney\nGeneral, visit www.ksfcounsel.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ksfcounsel.com&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=www.ksfcounsel.com&index=4&md5=7b8eca7680f79fdc4968980e07996cbb)\n.\n\nCONNECT WITH US: Facebook\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.facebook.com%2Fprofile.php%3Fid%3D61575733915628&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=Facebook&index=5&md5=d536aed12280dd2034448914f9d529a8)\n|| Instagram\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.instagram.com%2Fkahn_swick_and_foti%2F&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=Instagram&index=6&md5=5b3b14e507f6ea8cdd8649d1d31453f2)\n|| YouTube\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.youtube.com%2F%40kahnswickandfoti&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=YouTube&index=7&md5=c3c2a03a4620e3e1d0449a21160abf8c)\n|| TikTok\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.tiktok.com%2F%40kahn.swick.foti&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=TikTok&index=8&md5=7bb74d49797e5dac69f682b72879b80e)\n|| LinkedIn\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fksfcounsel&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=LinkedIn&index=9&md5=b78ee64867bfbc091f3b2a04b3c453fd)\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260910830014/en/\n(https://www.businesswire.com/news/home/20260910830014/en/)\n\nKahn Swick & Foti, LLC\n\nLewis S. Kahn, Managing Partner\n\nlewis.kahn@ksfcounsel.com \n(mailto:lewis.kahn@ksfcounsel.com) \n(833) 538-3612\n\n1100 Poydras St., Suite 960\n\nNew Orleans, LA 70163\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw4dPMpPa-20260910","title":"Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI","author":"Business Wire","ticker":"SMTI","created":"2026-09-10T20:10:00.216Z","tickers":["SMTI"],"exchange":"NASDAQ","article_body":"Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates\nAdequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI\n\nFormer Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law\nfirm of Kahn Swick & Foti\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ksfcounsel.com%2F&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=Kahn+Swick+%26amp%3B+Foti&index=1&md5=fd7f7d19ac27ca4fedc258b1cbe11aab)\n, LLC (“KSF”) are investigating the proposed sale of Sanara MedTech\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqcm-smti%2F&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=Sanara+MedTech&index=2&md5=e4a914385aace2d10264fe7e56cdc911)\nInc. (NasdaqCM: SMTI) to MiMedx Group, Inc. (NasdaqCM: MDXG). Under the terms\nof the proposed transaction, shareholders of Sanara will receive $33.00 in\ncash and 0.4735 shares of MiMedx common stock for each share of Sanara that\nthey own. KSF is seeking to determine whether this consideration and the\nprocess that led to it are adequate, or whether the consideration undervalues\nthe Company.\n\nIf you believe that this transaction undervalues the Company and/or if you\nwould like to discuss your legal rights regarding the proposed sale, you may,\nwithout obligation or cost to you, e-mail or call KSF Managing Partner Lewis\nS. Kahn (lewis.kahn@ksfcounsel.com (mailto:lewis.kahn@ksfcounsel.com) ) toll\nfree at any time at (833) 538-3612, or visit\nhttps://www.ksfcounsel.com/cases/nasdaqcm-smti/\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqcm-smti%2F&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=https%3A%2F%2Fwww.ksfcounsel.com%2Fcases%2Fnasdaqcm-smti%2F&index=3&md5=40e0900b5fa6c593f239ab7b03742f17)\nto learn more.\n\nTo learn more about KSF, whose partners include the Former Louisiana Attorney\nGeneral, visit www.ksfcounsel.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ksfcounsel.com&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=www.ksfcounsel.com&index=4&md5=7b8eca7680f79fdc4968980e07996cbb)\n.\n\nCONNECT WITH US: Facebook\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.facebook.com%2Fprofile.php%3Fid%3D61575733915628&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=Facebook&index=5&md5=d536aed12280dd2034448914f9d529a8)\n|| Instagram\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.instagram.com%2Fkahn_swick_and_foti%2F&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=Instagram&index=6&md5=5b3b14e507f6ea8cdd8649d1d31453f2)\n|| YouTube\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.youtube.com%2F%40kahnswickandfoti&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=YouTube&index=7&md5=c3c2a03a4620e3e1d0449a21160abf8c)\n|| TikTok\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.tiktok.com%2F%40kahn.swick.foti&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=TikTok&index=8&md5=7bb74d49797e5dac69f682b72879b80e)\n|| LinkedIn\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fksfcounsel&esheet=54601937&newsitemid=20260910830014&lan=en-US&anchor=LinkedIn&index=9&md5=b78ee64867bfbc091f3b2a04b3c453fd)\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260910830014/en/\n(https://www.businesswire.com/news/home/20260910830014/en/)\n\nKahn Swick & Foti, LLC\n\nLewis S. Kahn, Managing Partner\n\nlewis.kahn@ksfcounsel.com \n(mailto:lewis.kahn@ksfcounsel.com) \n(833) 538-3612\n\n1100 Poydras St., Suite 960\n\nNew Orleans, LA 70163\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-09-10T20:10:00.254508088Z","server_sent_at_ms":1789071000254},"received_at":"2026-09-10T20:10:00.312Z","source_url":"https://www.businesswire.com/news/home/20260910830014/en/"},"analysis":{"id":"129826","press_release_id":"140990","analysis_json":{"industry":{"label":"Health Care Equipment","sector":"Health Care"},"redFlags":["KSF investigating adequacy of merger consideration and process — signals a potential undervaluation claim against the SMTI/MDXG deal terms"],"eventType":"legal_litigation","narrative":"Kahn Swick & Foti, LLC, the investor-rights firm led by former Louisiana Attorney General Charles C. Foti Jr., is investigating the adequacy of the price and process in Sanara MedTech's proposed sale to MiMedx Group.\n\nUnder the proposed transaction, Sanara shareholders would receive $33.00 in cash plus 0.4735 MiMedx shares for each Sanara share owned; KSF is probing whether that consideration undervalues the company.\n\nThe release is a law-firm solicitation urging shareholders who believe the deal undervalues Sanara to contact the firm at no cost or obligation — law-firm marketing rather than a new disclosure from the issuer.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation on the SMTI/MDXG merger — suppress as noise; the substantive story remains the $33.00 cash plus 0.4735-share deal terms."},"keyFigures":{"customDimensions":{"stock_exchange_ratio":"0.4735 MiMedx (MDXG) shares per Sanara share","cash_consideration_per_share":33}},"namedEntities":{"people":[{"name":"Charles C. Foti, Jr.","role":"Former Attorney General of Louisiana; Kahn Swick & Foti partner"},{"name":"Lewis S. Kahn","role":"KSF Managing Partner"}],"products":[],"companies":[{"name":"Kahn Swick & Foti, LLC","relationship":"plaintiff law firm"},{"name":"Sanara MedTech Inc.","ticker":"SMTI","relationship":"target"},{"name":"MiMedx Group, Inc.","ticker":"MDXG","relationship":"acquirer"}],"dollarAmounts":[{"amount":"$33.00","context":"cash consideration per Sanara share in the proposed sale to MiMedx"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation issued by Kahn Swick & Foti investigating the already-announced SMTI/MDXG merger; no new issuer disclosure, no certified class, no settlement announced. Routine investor-rights marketing."},"tickerRelevance":{"others":[{"ticker":"MDXG","relevance":"acquirer"}],"primary":"SMTI"},"globalImportance":22,"audienceRelevance":14,"eventTypeSecondary":["m_and_a"],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-investigation-solicitation","certifiedClass":false,"issuerAuthored":false,"underlyingDeal":"proposed MiMedx (MDXG) acquisition of Sanara MedTech at $33.00 cash + 0.4735 MDXG shares per share","settlementAnnounced":false}},"event_type":"legal_litigation","event_type_secondary":["m_and_a"],"sentiment":"neutral","material_impact_score":1,"narrative":"Kahn Swick & Foti, LLC, the investor-rights firm led by former Louisiana Attorney General Charles C. Foti Jr., is investigating the adequacy of the price and process in Sanara MedTech's proposed sale to MiMedx Group.\n\nUnder the proposed transaction, Sanara shareholders would receive $33.00 in cash plus 0.4735 MiMedx shares for each Sanara share owned; KSF is probing whether that consideration undervalues the company.\n\nThe release is a law-firm solicitation urging shareholders who believe the deal undervalues Sanara to contact the firm at no cost or obligation — law-firm marketing rather than a new disclosure from the issuer.","key_figures":{"customDimensions":{"stock_exchange_ratio":"0.4735 MiMedx (MDXG) shares per Sanara share","cash_consideration_per_share":33}},"named_entities":{"people":[{"name":"Charles C. Foti, Jr.","role":"Former Attorney General of Louisiana; Kahn Swick & Foti partner"},{"name":"Lewis S. Kahn","role":"KSF Managing Partner"}],"products":[],"companies":[{"name":"Kahn Swick & Foti, LLC","relationship":"plaintiff law firm"},{"name":"Sanara MedTech Inc.","ticker":"SMTI","relationship":"target"},{"name":"MiMedx Group, Inc.","ticker":"MDXG","relationship":"acquirer"}],"dollarAmounts":[{"amount":"$33.00","context":"cash consideration per Sanara share in the proposed sale to MiMedx"}]},"model_name":"glm-5.3-flash","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-10T20:10:35.661Z","global_importance":22,"audience_relevance":14,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-investigation-solicitation","certifiedClass":false,"issuerAuthored":false,"underlyingDeal":"proposed MiMedx (MDXG) acquisition of Sanara MedTech at $33.00 cash + 0.4735 MDXG shares per share","settlementAnnounced":false}},"durationMs":35341,"modelName":"glm-5.3-flash"}}